Bronchial Asthma
Conditions
Brief summary
Asthma is a significant public health threat, affecting more than 300 million individuals globally. Asthma is classified as a non-communicable disease and leads to reduced quality of life, poor physical functioning and reduced emotional well-being. The impact of this disease can be widespread and extends beyond the person living with the disease, affecting the lives of their family members, carers, communities and the health care system (1). Asthma is a variable chronic respiratory condition. It is characterized by symptoms of wheeze, cough, chest tightness, dyspnea and backed by variable airflow limitation, airway inflammation and airway hyper-responsiveness (AHR). The severity of asthma varies considerably, both between individuals and within individuals over time. Some people may have intermittent asthma and others may experience severe, potentially life-threatening disease (2, 3,4).
Interventions
DRUGcorticosteroids
inhailed or oral corticosteroids
Sponsors
Sohag University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* bronchial asthma patients aged more than 18 years, both sexes are included
Exclusion criteria
* children ,patients who are unable to do spiromerty or contrindecated
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| percent of controlled bronchial asthma patients | 12 months | to detect percent of controlled patients |
Countries
Egypt
Contacts
Primary ContactDoha M ismail, Resident
Backup ContactKamal A Atta, Professor
Outcome results
None listed